OBJECTIVE: The purpose of this report is to evaluate the value of urinary @entity8273 ( @entity8273 ) as a maker of @entity1606 ( @entity1606 ). @entity1 AND METHODS: Urine samples were collected from 83 @entity1 hospitalized for transurethral resection (TUR). @entity1 ages ranged from 36 to 86 years. Samples were taken both before and after surgery. @entity8273 analysis was performed using an "ELISA-like" fluorometric assay. RESULTS: @entity1 were divided into two groups: a control group whose previous diagnosis was negative for @entity5 (n=22) and another with positive diagnosis for @entity5 (n=61) which was further sub-divided into with and without @entity41 . After the second procedure 47 individuals did not display @entity41 , whereas 14 (23%) did. The average @entity8273 in the control group was 8.3 microg/L pre- and 7.1 post-operatively, hence, no change occurred (p=0.471). In the group with @entity1606 @entity1 , the @entity8273 dropped from 885.5 microg/L to 215.3 microg/L with @entity41 and from 234.3 microg/L to 11.2 microg/L for those without @entity41 . Using a cut-off value of 20 microg/L, the sensitivity to detect @entity41 is 92.9% and specificity is 83%. CONCLUSION: @entity8273 in addition to being one of the best markers for the initial evaluation of @entity150 can be used to determine the presence of a @entity41 . This is associated with poor prognosis.

Urinary @entity8273 as a marker for the presence of XXXX of the urinary bladder.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'PATIENTS', 'Patient'] @entity8273 :: ('MESH:C565742', 'Disease') :: ['HA', 'hyaluronan'] @entity41 :: ('MESH:D018365', 'Disease') :: ['residual tumors', 'residual tumor'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors'] @entity1606 :: ('MESH:D002295', 'Disease') :: ['residual transitional cell carcinoma', 'TCC'] @entity150 :: ('MESH:D001749', 'Disease') :: ['bladder carcinoma']
@entity1606 :: (MESH:D002295,Disease) :: ['residual transitional cell carcinoma']
